The Division of Hematology is an academic unit within the Department of Internal Medicine that is committed to research (basic, translational, and clinical), education, and outstanding outpatient and inpatient clinical care of patients with non-malignant and malignant blood disorders. The major focus in the Division of Hematology is performing transforming research that translates basic findings to the bedside where new therapies are applied for the treatment of benign and malignant blood cancers. Additionally, the Division of Hematology is pro-active in the introduction of novel treatment approaches in blood and bone marrow transplantation with national leadership in both the Cancer and Leukemia Group B (CALGB) and Clinical Trials Network (CTN). The Division of Hematology is highly committed to training basic, translational, and clinical physician scientists both as part of the Internal Medicine residency program and also as fellows in the Hematology and Medical Oncology Fellowship program. Patient care provided by members of the Division of Hematology in the James Cancer Hospital and Solove Research Institute is focused on a compassionate, personalized medicine approach.
- John Byrd, MD, Division Director